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In this issue of the Journal, Charles Fisch (1) presents an
excellent overview of the birth and development of the
electrocardiograph machine. His article provides insightful
commentary by an expert electrocardiographer who has
spent a professional lifetime using that device to make
See page 1737
fundamental observations about cardiac pathophysiology.
The purpose of this editorial comment is to expand the
findings covered in that review to demonstrate how clinical
investigators have applied those advances in electrocardiog-
raphy toward an understanding of the physiology of cardiac
arrhythmias (2–4). This knowledge has enabled the prac-
ticing cardiologist, armed with no more than a pair of
calipers and deductive reasoning, to use the 12-lead elec-
trocardiogram (ECG) to diagnose arrhythmias in ways that
rival the clinical electrophysiologist. In fact, the early elec-
trocardiographers did just that, and the advent of invasive
clinical electrophysiology has proven their insight correct in
many instances, ranging from observations about concealed
conduction, accessory pathway (Wolff-Parkinson-White)
tachycardias, aberration, focal causes of atrial fibrillation,
ventricular tachycardias, and others. Let us consider a few of
the lessons that they learned.
Interpretation of supraventricular tachycardias. Based on
their ECG presentation, paroxysmal supraventricular tachy-
cardias (SVTs) can be classified into two major groups:
short RP and long RP tachycardias, that is, the P wave
during the SVT occurs either in the first or second half of
the tachycardia cycle. Because the PR interval is inversely
related to the RP interval, short RP tachycardias have a long
PR interval, and long RP tachycardias have a short PR
interval. Although exceptions to any classification are to be
expected, this grouping includes the vast majority of SVTs
and enables the clinician to deduce the SVT mechanism
with relative ease and accuracy. From that information,
appropriate therapeutic decisions follow.
SHORT RP SVTs. These SVTs are defined by having atrial
activity 1) obscured by the QRS complex because of the
simultaneous inscription of both, 2) occurring in the termi-
nal portion of the QRS complex and often giving the
appearance of an R9 in lead V1, or 3) present in the ST
segment. Hence, the interval from the onset of the QRS
complex to the onset of the P wave is short—“short RP
SVT”—and in fact can be a negative value when the
retrograde P wave is buried in the beginning portion of the
QRS complex. Invasive electrophysiologic studies have
shown that the most likely SVT for the first and second
examples is atrioventricular nodal reentrant tachycardia
(AVNRT), using the slow AV nodal pathway anterogradely
and the fast AV nodal pathway retrogradely. An SVT
traveling to the ventricle over the AV node and back to the
atrium over an accessory pathway, called “atrioventricular
reentrant tachycardia” (AVRT; Wolff-Parkinson-White
syndrome), is the most likely cause of the third example, and
less commonly the second. Thus, careful study of the ECG
can explain these very common SVTs.
One can become even more sophisticated in diagnosing
the SVT if an episode of functional bundle branch block
(FBBB) also occurs. Prolongation of the SVT cycle length
during FBBB is most consistent with an AVRT and the
location of the accessory in the same ventricle that gave rise
to the FBBB. Thus, prolongation of the SVT cycle length
during a period of a functional left bundle branch block
(LBBB) would be found during AVRT due to retrograde
conduction over a left-sided accessory pathway; the same
reasoning applies to functional right BBB (RBBB) and a
right-sided accessory pathway. The cycle length of the SVT
prolongs because, during the FBBB, the anterograde im-
pulse must first activate the ventricle contralateral to the site
of FBBB and then travel across the interventricular septum
to reach the opposite ventricle, gain access to the accessory
pathway, and activate the atrium retrogradely. Failure of the
FBBB to prolong the cycle length of the AVRT occurs
when the accessory pathway is located contralateral to the
ventricle with the FBBB, in many AVRTs due to septal
accessory pathways, and during non-WPW forms of SVT.
The ECG algorithms based on the morphology of the delta
wave of the WPW complex can also be used to determine
the location of the accessory pathway.
LONG RP SVTs. These SVTs are characterized electrocardio-
graphically by atrial activity located “just before” the next
QRS complex, so that the P wave is located in the second
half of the tachycardia cycle at a conductible PR interval of
#300 ms or so. As such, this SVT creates a long interval
from the preceding QRS complex to the next P wave. This
type of ECG presentation is typical of an atrial tachycardia
and two other SVTs. One is an unusual form of AVRT
comprised of a slowly conducting accessory pathway that
creates an incessant SVT, which pauses briefly for a few
sinus beats and then resumes. This is called the “permanent
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form of junctional reciprocating tachycardia,” or PJRT, and
is important clinically because the incessant nature of the
SVT can cause a tachycardia-induced cardiomyopathy. The
impulse in PJRT travels to the ventricles over the normal
conducting system and then back to the atria over the slowly
conducting accessory pathway. The third type of long RP
SVT is an unusual form of AVNRT, during which the
impulse travels to the ventricle over the fast-conducting AV
nodal pathway, and retrogradely over the slow-conducting
pathway. In essence, it is the reverse route traveled by the
usual type of AVNRT noted earlier in the text.
INTERMEDIATE RP TACHYCARDIA. Several infrequently oc-
curring SVTs can give rise to tachycardias that have PR and
RP intervals of about the same duration so that the P wave is
found midway in the tachycardia cycle. They include AVNRT
when the impulse travels over two slowly conducting pathways,
unusual forms of AVRTs, and some atrial tachycardias.
SPONTANEOUS ONSET OR TERMINATION OF THE SVT. A
sustained SVT initiated by a premature atrial complex
(PAC) causing block in an accessory pathway is most likely
an AVRT, whereas a sustained SVT started by a PAC that
significantly prolongs the PR interval is probably AVNRT.
Documenting the termination of the SVT can also
provide a clue as to its mechanism. An SVT always stopping
with a P wave rather than a QRS complex as the electrical
event last inscribed in the ECG is unlikely to be an atrial
tachycardia, because the atrial focus would always have to
block en route to the ventricle at the same time it stopped
discharging, an unlikely set of coincidences to happen repeat-
edly. Far more likely is either AVNRT or AVRT, during
which atrial activity blocks before reaching the ventricle, thus
interrupting the reentrant loop and terminating the tachycar-
dia. Similarly, an SVT that persists uninterruptedly despite
blocked P waves is almost certainly an atrial tachycardia, rarely
AVNRT, and never the usual forms of AVRT.
Atrial flutter and atrial fibrillation. ATRIAL FLUTTER. Al-
though atrial flutter can originate in either atrium, fre-
quently due to reentry around an area of fibrosis, the most
common form of atrial flutter is attributable to a large
reentrant loop confined to the right atrium that travels in a
counterclockwise direction, caudocranially in the interatrial
septum and craniocaudally in the right atrial free wall. This
common form of atrial flutter is characterized electrocardio-
graphically by sawtooth flutter waves that are negative in
leads II, III, and aVF and show continual electrical activity
(lack of an isoelectric interval between flutter waves). In this
type of atrial flutter, an area of slow conduction is present in the
posterolateral to posteromedial inferior right atrium, between
the tricuspid valve annulus and the inferior vena cava orifice.
This critical isthmus of slowed conduction is crucial to the
maintenance of the reentrant conduction and represents the
site of successful ablation that eliminates atrial flutter.
ATRIAL FIBRILLATION. The exciting new development in
our thinking about atrial fibrillation is the recognition that
discharge from a single rapidly firing focus can precipitate
and perpetuate this tachycardia (5). The controversy over
whether multiple wavelets of reentry cause atrial fibrillation
or a single rapidly firing focus causes atrial fibrillation has
existed for 50 years. Laboratory and clinical data have
supported both concepts, and very probably both forms exist
clinically. However, the fact that a single focus can definitely
cause some forms of atrial fibrillation facilitates catheter
ablation to eliminate the arrhythmia and, thus, offers a cure
for some patients. Patients with this type of atrial fibrillation
are frequently young with structurally normal hearts, have
paroxysmal episodes, and the ECG often shows bursts of an
atrial tachycardia or frequent premature atrial complexes,
sometimes initiating the atrial fibrillation. Fascinatingly, the
atrial focus is most commonly located in the pulmonary
veins, more often in the upper than in the lower veins, and
can be ablated by transseptal catheter techniques. The
P-wave morphology of the PAC or atrial tachycardia can be
used to help locate the responsible pulmonary vein.
Interpretation of wide complex tachycardias. Distin-
guishing aberrant ventricular conduction of supraventricular
origin from a ventricular tachycardia (VT) is critical for
making appropriate patient management decisions. As with
the analysis of SVTs, the 12-lead ECG can provide clues—
based on the presence of specific QRS cycle sequences, QRS
morphology, and the relationship of P waves to QRS
complexes—that enable the clinician in most instances to
diagnose SVT versus VT.
Fusion and capture complexes, and the presence of AV
dissociation, provide the strongest ECG evidence of VT; a
tachycardia consistently starting with a premature P wave,
having a very short (100 ms) RP interval, a QRS configu-
ration known to be supraventricular, P-wave and QRS com-
plex linked to suggest that ventricular activation depends on
atrial discharge, and slowing or termination of the tachycardia
by vagal maneuvers, are all consistent with an SVT.
Analysis of specific QRS contours during the tachycardia
can be helpful in diagnosing VT, and include a QRS with
left axis deviation and a duration exceeding 140 ms, with a
normal duration during sinus rhythm. During VT with a
RBBB appearance, the QRS complex in lead V1 is often
monophasic or biphasic with an initial deflection different
from that of the sinus-initiated complex, and it has a small
R and large S wave or a QS pattern in lead V6. During an
LBBB pattern, the QRS axis can be rightward and have a
broad, prolonged (exceeding 40 ms) R wave in lead V1 and
a small Q–large R wave or QS pattern in lead V6. Aberrant
supraventricular complexes often have an RSR9 in lead V1
and are initiated by a long–short cycle sequence. A wide
complex tachycardia with irregular intervals, and rates ex-
ceeding 200/min, should raise the question of atrial fibril-
lation and conduction over an accessory pathway. Other
ECG features can be helpful, and various algorithms have
been applied. It is important to stress that exceptions to all
of the above criteria exist, and one must rely on sound
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clinical judgment and consider the ECG only one of several
helpful ancillary tests.
LESS COMMON FORMS OF VTS. The 12-lead ECG during
sinus rhythm or VT often contains distinctive features that
provide insight into the nature of the underlying heart disease,
the location of the VT (important for catheter ablation), or the
mechanism responsible for the VT. Each of these factors can
be helpful in making therapeutic decisions and in advising the
patient about his or her prognosis. Although in-depth descrip-
tion of these characteristics can be found in more comprehen-
sive reports (3,4), several aspects will be reviewed here.
The presence of an RSR9 in lead V1 associated with
upward coving of the ST segment in leads V1 through V3
and a normal QT interval may indicate that the patient has
the newly described Brugada syndrome, an inherited genetic
disorder affecting the repolarization function of the sodium
channel (6). Interestingly, a slightly different abnormality of the
same gene, which in the Brugada syndrome does not prolong
repolarization, is also responsible for one of the long QT
syndromes (LQT3). The Brugada syndrome is characterized
clinically by ventricular tachyarrhythmias and sudden death,
and it may be responsible for the so-called “night terrors” of
many Asian cultures (3). The symptomatic patient requires
treatment with an implantable cardioverter defibrillator (ICD).
Finding a prolonged QT interval during sinus rhythm
signifies an inherited or acquired repolarization disorder
called the “long QT syndrome” (LQTS) (7). The inherited
form of LQTS has as many as six different responsible
genotypes with several phenotypes, and can predispose to a
specific kind of VT, called “torsade de pointes.” This VT
has a characteristic polymorphic ECG appearance of the
QRS, which appears to be “twisting about on its points.” A
fairly specific electrophysiologic mechanism, “early afterde-
polarizations,” caused by a malfunctioning sodium or po-
tassium channel, appears to be responsible for torsade de
pointes, which can be treated by drugs or an ICD. An
unknown number of youngsters present with seizures due to
hypotension from the torsade de pointes, and they are
misdiagnosed with epilepsy. Some patients predisposed to
drug-induced, acquired LQTS may actually have an inher-
ited form that makes them vulnerable to the QT-
prolonging, proarrhythmic effects of many drugs.
Several types of cardiomyopathies can cause ventricular
tachyarrhythmias and may demonstrate uniquely appearing
ECGs during sinus rhythm. For example, arrhythmogenic
right ventricular cardiomyopathy (8) can be characterized
during sinus rhythm by an epsilon wave (a notch on the
terminal portion of the QRS in lead V1 due to delayed right
ventricular activation) and T-wave negativity in the anterior
precordial leads. This disorder, due to fatty replacement of
the right and, less commonly, left ventricular myocardium,
can result in lethal ventricular arrhythmias. Patients with
hypertrophic cardiomyopathy (9) can exhibit large voltages
consistent with ventricular hypertrophy and deep Q waves
often confused with myocardial infarction, whereas patients
who have muscular dystrophy (10) can have tall R waves in
the anterior precordial leads reminiscent of a true posterior
myocardial infarction. Patients with a dilated cardiomyop-
athy can have VT due to bundle branch reentry that often
has an LBBB contour and can be treated with radiofre-
quency catheter ablation.
Finally, two types of VTs that occur in patients with
apparently structurally normal hearts include those originat-
ing in the right ventricular outflow tract that have a
LBBB–inferior axis morphology, and those coming from
the left ventricular septum that have a RBBB and left axis
deviation contour. Both are relatively easily eliminated with
radiofrequency catheter ablation.
Conclusions. It is clear from this brief accounting that the
ECG has become an essential tool in diagnosing cardiac
arrhythmias. Naturally, the ECG has many other important
clinical applications not reviewed in this article. The ECG
interpretation of arrhythmias has been greatly aided by the
work of electrophysiologists who, over the last 30 years,
have forged an impressive foundation of knowledge using
invasive techniques. Today, a skilled electrocardiographer
wielding a pair of calipers can feel quite comfortable in
understanding a broad array of arrhythmias based on a
careful study of a 12-lead ECG.
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